Anticanceragent 191 (Compound 2) is a probenecid derivative. It functions as an efflux inhibitor targeting cancer cells by inhibiting P-glycoprotein (P-gp), breast cancer resistance protein (BCRP), and/or multiple multidrug resistance proteins (MRPs). Anticanceragent 191 enhances the accumulation of vincristine within cancer cells and is utilized for cancer research.
Formula:
C19H31N3O5S
Target:
BCRP|||P-gp
* VAT and and shipping costs not included. Errors and price changes excepted